Brief: Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC Filing
May 7 (Reuters) - SEC Filing: JADE BIOSCIENCES INC - MAY OFFER AND SELL UP TO $600 MILLION OF SECURITIES - SEC FILING JADE BIOSCIENCES INC - MAY OFFER AND SELL UP TO $200 MILLION COMMON STOCK UNDER SALES AGREEMENT WITH JEFFERIES - SEC FILING Source text: [ID:n0001193125-26-212422] Further company coverage: JBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million